XiFin Pharmacy Solutions invites pharmacy professionals to share insights on critical success factors

XiFin Pharmacy Solutions invites pharmacy professionals to participate in the 2025 Pharmacy Transformation Study aimed at uncovering critical success factors that will shape the future of pharmacy care. 

As evidence mounts regarding the increasing impact of pharmacists on health outcomes, this survey builds on the findings of the 2024 Pharmacy Transformation Study conducted by XiFin Pharmacy Solutions. It seeks to explore how pharmacists are bridging primary care gaps and transforming pharmacies into essential health and wellness hubs, especially in underserved areas. 

For instance, by using new alerting technology, participating pharmacies successfully increased companion pneumococcal immunizations by 28%, a notable increase considering, during the 2021-2022 influenza season, only about 49.4% of US adults were vaccinated against the flu. The 2025 survey seeks to understand the opportunities and gaps that exist as pharmacists expand their services.

[Read more: XiFin Pharmacy Solutions' webinar focuses on how the industry can propel pharmacy forward]

"Pharmacists are at the heart of healthcare transformation," said David Pope, chief pharmacy officer at XiFin. "As trusted healthcare providers, they are increasingly relied upon to deliver clinical services, help manage chronic conditions and contribute to preventive care. We are incredibly proud to support these healthcare champions by providing them with the solutions they need to continue delivering exceptional care. Their expertise, compassion, and commitment inspire us, and we look forward to continuing this journey alongside them."

Findings from the 2024 Pharmacy Transformation Study emphasized the expanding role of pharmacists in health care, revealing significant growth opportunities for pharmacies offering a wider range of clinical services, including generating new revenue. With pharmacies increasingly filling community healthcare gaps, the 2025 study will probe deeper into the people, process and technology considerations and investments needed to fuel growth opportunities, including:

• Value-Based Care Transition: examine how the ongoing shift from fee-for-service to value-based care presents a key opportunity for pharmacists, who will increasingly be recognized as vital partners in delivering holistic care while improving access for underserved populations.
• Chronic Care Management: capture views on expanding pharmacist-led chronic care management for complex, medication-heavy conditions that require multiple therapies and ongoing monitoring and support.
• Closing Revenue Gaps Related to Clinical Services and Specialty Medications: examine the potential unrealized revenue related to clinical services delivery and specialty therapeutics, enabling pharmacies to enhance their financial sustainability while also increasing essential patient care as the state-level scope of pharmacist-led care continues to expand.
• Pharmacies as Health and Wellness Hubs: explore increases in clinical services such as screenings, education and preventative care reflecting the industry's shift toward a more integrated healthcare model. This includes immunizations, which are now a standard offering at many pharmacies, with 75% of 2024 respondents offering these services.
• Payor Dynamics and Pharmacy Claim Processing: examine the status of existing and future payor contracts, awareness of different pharmacy billing pathways and the expected shifts in the coming years.

[Read more: OmniSYS is now XiFin Pharmacy Solutions]

To participate in the study, click here.